A New Research Study is available in your area
Do you have Chronic Obstructive Pulmonary Disease (COPD)?
Learn about a no-cost, new investigational drug to potentially treat symptoms of moderate to severe COPD in former smokers.
Do you struggle with moderate-to-severe COPD?
Chronic Obstructive Pulmonary Disease (COPD) is a serious and life-threatening disease. In the United States, chronic lower respiratory diseases are a leading cause of death, and tobacco smoke, pollutants and airborne contaminants are leading contributors to COPD. COPD causes progressive decline in lung function and recurrent exacerbation of symptoms. Former and current smokers with COPD are particularly at risk for exacerbation of symptoms, which can result in hospitalization and more rapid disease progression.
If you’re a former smoker who is struggling with COPD, you may qualify for a new research study now offered at select centers in the United States. The study is testing an investigational treatment for moderate-to-severe Chronic Obstructive Pulmonary Disease in former smokers, with the potential to reduce exacerbations, improve lung function, and enhance the overall quality of life.
If you are eligible and participate, you will receive free study-related care, such as physical exams, lung function tests, laboratory tests, ECGs, and chest X-ray, at no cost.
FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA
✓ Have been diagnosed with COPD for at least 1 year
✓ Are a former smoker (have not smoked or vaped nicotine or THC products within 6 months)
✓ Have been on COPD inhaler for at least 3 months
About the study
Chronic Obstructive Pulmonary Disease is a common, chronic progressive lung disease that is characterized by persistent airflow limitation and respiratory symptoms like shortness of breath, cough, and sputum production.
The purpose of this clinical trial is to evaluate a new treatment to see if it can help reduce moderate-to-severe exacerbations of COPD in individuals who have quit smoking but still experience symptoms despite their current treatment. This trial aims to provide an additional treatment option to those who require further management of their COPD.
The clinical trial will take approximately 77 weeks to complete and include biweekly subcutaneous injections (injection under the skin), trial-related medical examinations, physical exams, lung function tests, laboratory tests, ECGs, chest x-ray, and assessments made by medical investigators.
There will be no cost associated with participation in the trial. You may receive compensation for transportation and the time required to participate in the trial.
If you’re a former smoker struggling with moderate-to-severe COPD, you may qualify for a new research study, now being offered at select centers throughout the U.S. The study is for an investigational study treatment designed to prevent worsening of COPD symptoms (exacerbations) in patients who were former smokers. If you qualify, you will receive:
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
The study includes physical exams, laboratory tests, ECGs, chest X-ray, and other examination visits with a trained investigator.
You might be eligible to receive compensation for your time and travel.
FILL OUT THE FORM BELOW
Chat With A Research Coordinator
Fill out the form below, and you will be advised if you are eligible. If you meet the initial pre-screening criteria, you will be contacted by someone from a research location near you. If you do not meet the minimum criteria, still submit the form. It is possible for study criteria to change, making you eligible at a later date.